Health technology assessment process of a cardiovascular medical device in four different settings

Area of Science:

• Health Technology Assessment (HTA)
• Medical Device Evaluation
• Health Economics

Background:

• Health technology assessment (HTA) is crucial for informed decision-making in healthcare.
• Drug-eluting stents (DES) represent a significant medical technology requiring rigorous evaluation.
• Understanding HTA processes is vital for effective reimbursement strategies.

Purpose of the Study:

• To describe the methods and processes of HTA for drug-eluting stents (DES).
• To compare HTA approaches in four distinct healthcare settings.
• To identify areas for improvement in the HTA of medical devices.

Main Methods:

• Selection of drug-eluting stents (DES) as the technology under study based on agreed criteria.
• Development and implementation of a survey for key informants.
• Analysis of HTA processes through a structured approach.

Main Results:

• Drug-eluting stents (DES) were evaluated using structured HTA processes.
• Identified areas for enhancement in data utilization for decision-making.
• Observed opportunities to improve transparency, inclusiveness, and methodological rigor in HTA.

Conclusions:

• The study describes the HTA processes for a prominent medical device, drug-eluting stents (DES).
• Findings highlight the need for refinement in HTA practices to optimize reimbursement decisions.
• Further research can build upon these insights to strengthen HTA frameworks.